Paolo Catarsi
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Understanding the link between PMN-MDSCs and CXCL8-CXCR1/2 axis in primary myelofibrosis.
Journal: Frontiers in cell and developmental biology
Published: February 11, 2026
Primary myelofibrosis with increased haemoglobin concentration at presentation.
Journal: British journal of haematology
Published: April 03, 2025
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis.
Journal: Cancers
Published: May 17, 2024
Circulating Mesenchymal Stromal Cells in Patients with Infantile Hemangioma: Evaluation of Their Functional Capacity and Gene Expression Profile.
Journal: Cells
Published: December 15, 2023
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression?
Journal: Blood cancer journal
Published: December 14, 2023
Cells coexpressing both myeloid and endothelial markers are detectable in the spleen and bone marrow of patients with primary myelofibrosis.
Journal: Experimental hematology
Published: April 21, 2022
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes.
Journal: Genes
Published: June 25, 2021
VEGFA rs3025020 Polymorphism Contributes to CALR -Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: April 15, 2021
Primary myelofibrosis: rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis.
Journal: Leukemia research
Published: March 20, 2021
Last Updated: 09/26/2026